Abstract | BACKGROUND: Methicillin-resistant or methicillin-sensitive Staphylococcus aureus skin and soft tissue infections pose serious clinical and public health challenges. Few protocols exist for outpatient education, decolonization and decontamination. OBJECTIVES: This trial implemented infection prevention protocols in homes via community health workers/Promotoras. METHODS: We engaged clinicians, patient stakeholders, clinical and laboratory researchers, New York-based federally qualified health centers and community hospital emergency departments. The Clinician and Patient Stakeholder Advisory Committee (CPSAC) convened in person and remotely for shared decision-making and trial oversight. RESULTS: The intervention trial consented participants with skin and soft tissue infections from Methicillin-resistant Staphylococcus aureus or methicillin-sensitive Staphylococcus aureus, completed home visits, obtained surveillance cultures from index patients and household members and sampled household environmental surfaces at baseline and three months. LESSONS LEARNED: The retention of the CPSAC during the trial demonstrated high levels of engagement. CONCLUSIONS: CPSAC was highly effective throughout design and execution by troubleshooting recruitment and home visit challenges.
|
Authors | Brianna D'Orazio, Jessica Ramachandran, Chamanara Khalida, Johana Gonzalez, Rhonda G Kost, Kimberly S Vasquez, Teresa H Evering, Tameir Holder, Getaw Worku Hassen, Regina Hammock, Rosalee Nguyen, Ronette Davis, Keenan Millan, Van Johnson, Claude Parola, Barry S Coller, Jonathan N Tobin |
Journal | Progress in community health partnerships : research, education, and action
(Prog Community Health Partnersh)
Vol. 16
Issue 1
Pg. 45-60
( 2022)
ISSN: 1557-055X [Electronic] United States |
PMID | 35342110
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
|
Topics |
- Community-Acquired Infections
(drug therapy, epidemiology)
- Community-Based Participatory Research
- Humans
- Methicillin
(therapeutic use)
- Methicillin-Resistant Staphylococcus aureus
- Soft Tissue Infections
(drug therapy, epidemiology)
- Stakeholder Participation
- Staphylococcal Infections
(prevention & control)
- Staphylococcus aureus
|